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Résumé en
anglais
INTRODUCTION: The most common form of axonal Charcot-Marie-Tooth (CMT)
disease is type 2A, caused by mutations in the mitochondrial GTPase mitofusin 2
(MFN2). OBJECTIVE: The objective of our study is to establish the incidence of
MFN2 mutations in a cohort of Spanish patients with axonal CMT neuropathy.
MATERIAL AND METHODS: Eighty-five families with suspected axonal CMT were
studied. All MFN2 exons were studied through direct sequencing. A bioenergetics
study in fibroblasts was conducted using a skin biopsy taken from a patient with an
Arg468His mutation. RESULTS: Twenty-four patients from 14 different families were
identified with nine different MFN2 mutations (Arg94Trp, Arg94Gln, Ile203Met,
Asn252Lys, Gln276His, Gly296Arg, Met376Val, Arg364Gln and Arg468His). All
mutations were found in the heterozygous state and four of these mutations had not
been described previously. MFN2 mutations were responsible for CMT2 in 16% +/-
7% of the families studied and in 30.8 +/- 14.2% (12/39) of families with known
dominant inheritance. The bioenergetic studies in fibroblasts show typical results of
MFN2 patients with a mitochondrial coupling defect (ATP/O) and an increase of the
respiration rate linked to complex II. CONCLUSION: It is concluded that mutations
in MFN2 are the most frequent cause of CMT2 in this region. The Arg468His
mutation was the most prevalent (6/14 families), and our study confirms that it is
pathological, presenting as a neuropathy in a mild to moderate degree. This study
also demonstrates the value of MFN2 studies in cases of congenital axonal
neuropathy, especially in cases of dominant inheritance, severe clinical symptoms or
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